EssilorLuxottica Société anonyme against Sanofi — live side-by-side technical comparison.
Prices as of 2026-10-09T15:35:03+00:00 UTC · updates daily
EL.PA leads 3 of the 5 windows we measure — over 1 month EL.PA is -1.8% and SNY -6.5%; over year to date EL.PA is -45.8% and SNY -17.3%.
| EL.PA | SNY | |
|---|---|---|
| Price | $146.35 | $40.07 |
| 1 day | +2.3%lead | -0.4% |
| 5 days | +2.5%lead | +0.4% |
| 1 month | -1.8%lead | -6.5% |
| 6 months | -25.8% | -14.9%lead |
| Year to date | -45.8% | -17.3%lead |
| 52-week position | 4% of range | 7% of range |
| 52-week range | $138.30–$323.80 | $39.18–$52.68 |
| vs 50-day average | below $154.26 | below $42.97 |
| vs 200-day average | below $191.96 | below $44.85 |
| RSI (14) | 58 | 27 |
| Next earnings | 2026-02-11 | 2026-10-30 |
EL.PA trades at $146.35, below its 50-day average of $154.26, and below the 200-day at $191.96. It sits at 4% of its 52-week range ($138.30–$323.80); 14-day RSI is 58, in neutral territory; an average session moves it about 2.8%. For levels, the first level overhead is $150.00 (2.5% away) and the first support below is $139.00 (5.0% down). On the checklist the page runs for every asset, 3 of 6 checks read bullish — the lean is mixed.
SNY trades at $40.07, below its 50-day average of $42.97, and below the 200-day at $44.85. It sits at 7% of its 52-week range ($39.18–$52.68); 14-day RSI is 27, in oversold territory; an average session moves it about 1.9%. For levels, the first level overhead is $41.19 (2.8% away) and the first support below is $40.00 (0.2% down). On the checklist the page runs for every asset, 1 of 6 checks read bullish — the lean is bearish.
EL.PA is the more volatile of the two — an average session moves it 2.8% against 1.9% for SNY, so an identical position size carries roughly 1.5× the daily risk.
The comparison turns on those levels: EL.PA clearing $150.00 or losing $139.00; SNY clearing $41.19 or losing $40.00. Until one of them gives way, the relative reading above stands.